Infinity Takes Right Blend Of Israel And China To Nurture Biotech Growth In Chinese Cities
This article was originally published in PharmAsia News
Executive Summary
By wedding proven technology transferred from Israel with a cost-effective manufacturing giant such as China, Tel Aviv-based investment firm Infinity Group has recently expanded its Chinese currency RMB funds I-China to seven Chinese cities, targeting pharmaceuticals, medical devices, healthcare and environmental services